![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
C07K 16/22 | |||
A61P 35/00 | |||
A61K 31/282 |
(11) | Number of the document | 3197493 |
(13) | Kind of document | T |
(96) | European patent application number | 15777810.1 |
Date of filing the European patent application | 2015-09-25 | |
(97) | Date of publication of the European application | 2017-08-02 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/052247 |
Date | 2015-09-25 |
(87) | Number | WO 2016/049470 |
Date | 2016-03-31 |
(30) | Number | Date | Country code |
201462055203 P | 2014-09-25 | US |
(72) |
GYURIS, Jeno, US
LERNER, Lorena, US
LIN, Jie, US
|
(73) |
Aveo Pharmaceuticals Inc.,
1 Broadway 14th Floor, Cambridge, MA 02142,
US
|
(54) | METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT |
METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT |